Accrued Liabilities, Current in USD of Sonnet BioTherapeutics Holdings, Inc. from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Accrued Liabilities, Current history and change rate from Q4 2010 to Q2 2023.
  • Sonnet BioTherapeutics Holdings, Inc. Accrued Liabilities, Current for the quarter ending 30 Jun 2023 was $3,315,404, a 3.47% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $3,315,404 +$111,266 +3.5% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $3,112,282 +$1,007,346 +48% 31 Mar 2023 10-Q 10 May 2023 2023 Q2
Q4 2022 $3,538,212 +$1,791,096 +103% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 $3,193,972 +$883,562 +38% 30 Sep 2022 10-Q 14 Aug 2023 2023 Q3
Q2 2022 $3,204,138 +$695,182 +28% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q1 2022 $2,104,936 -$790,800 -27% 31 Mar 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 $1,747,116 -$699,398 -29% 31 Dec 2021 10-Q 08 Feb 2022 2022 Q1
Q3 2021 $2,310,410 +$246,732 +12% 30 Sep 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 $2,508,956 +$1,806,122 +257% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 $2,895,736 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 $2,446,514 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $2,063,678 +$1,238,813 +150% 30 Sep 2020 10-K 17 Dec 2021 2021 FY
Q2 2020 $702,834 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q3 2019 $824,865 30 Sep 2019 10-K 17 Dec 2020 2020 FY
Q2 2012 $13,681 +$4,093 +43% 30 Jun 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 $110,813 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 $21,521 -$44,582 -67% 31 Dec 2011 10-Q 13 Aug 2012 2012 Q2
Q3 2011 $13,071 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 $9,588 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 $66,103 31 Dec 2010 10-K 06 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.